Baillie Gifford & Co Portfolio holdings
Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.
Top Buys
| 1 |
Carvana
CVNA
|
$1.27B |
| 2 |
KE Holdings
BEKE
|
$903M |
| 3 |
Datadog
DDOG
|
$568M |
| 4 |
Cloudflare
NET
|
$551M |
| 5 |
Beyond Meat
BYND
|
$488M |
Top Sells
| 1 |
Tesla
TSLA
|
$10.4B |
| 2 |
Alibaba
BABA
|
$4.62B |
| 3 |
Amazon
AMZN
|
$1.64B |
| 4 |
TSMC
TSM
|
$1.15B |
| 5 |
Meta Platforms (Facebook)
META
|
$897M |
Sector Composition
| 1 | Consumer Discretionary | 37.6% |
| 2 | Technology | 17.1% |
| 3 | Communication Services | 14.8% |
| 4 | Healthcare | 14.03% |
| 5 | Financials | 5.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
176
T Rowe Price
TROW
$24.5B
| $22.8M | 0.02% |
177,619
+1,854
| +1% | +$238K |
|
|
AMBR
177
Amber International Holding Limited American Depositary Shares
AMBR
$354M
| $22.2M | 0.02% |
333,479
+103,727
| +45% | +$6.92M |
|
178
Medtronic
MDT
$119B
| $21.7M | 0.01% |
208,887
+3,334
| +2% | +$346K |
|
|
RUBY
179
DELISTED
Rubius Therapeutics, Inc
RUBY
| $21.4M | 0.01% |
4,273,861
+19,129
| +0.4% | +$95.8K |
|
|
TTM
180
DELISTED
Tata Motors Limited
TTM
| $20.6M | 0.01% |
+2,261,383
| New | +$20.6M |
|
181
Edwards Lifesciences
EW
$47.5B
| $20.2M | 0.01% |
253,481
+58,738
| +30% | +$4.69M |
|
182
Waters Corp
WAT
$17.8B
| $20.1M | 0.01% |
102,465
-1,385,896
| -93% | -$271M |
|
|
DADA
183
DELISTED
Dada Nexus
DADA
| $19.3M | 0.01% |
729,694
+346,217
| +90% | +$9.16M |
|
184
Dolby
DLB
$6.98B
| $19.2M | 0.01% |
289,840
+9,322
| +3% | +$618K |
|
185
CEVA Inc
CEVA
$534M
| $19.1M | 0.01% |
485,455
+20,887
| +4% | +$822K |
|
|
ZUO
186
DELISTED
Zuora, Inc.
ZUO
| $17.4M | 0.01% |
1,684,777
+248,017
| +17% | +$2.56M |
|
|
API
187
Agora
API
$299M
| $17.2M | 0.01% |
400,000
| – | – |
|
188
HEICO
HEI
$44.9B
| $17M | 0.01% |
162,848
-10,773
| -6% | -$1.13M |
|
189
Sutro Biopharma
STRO
$86.5M
| $17M | 0.01% |
1,695,654
+195,654
| +13% | +$1.97M |
|
190
Digimarc
DMRC
$175M
| $17M | 0.01% |
761,398
-1,845
| -0.2% | -$41.2K |
|
191
Visa
V
$681B
| $16.3M | 0.01% |
81,362
-3,087,441
| -97% | -$617M |
|
|
NCNA
192
NuCana
NCNA
$5.46M
| $15.8M | 0.01% |
610
+445
| +270% | +$11.5M |
|
193
Veeco
VECO
$1.44B
| $15.4M | 0.01% |
1,319,659
-3,285
| -0.2% | -$38.3K |
|
194
Cullen/Frost Bankers
CFR
$8.38B
| $14.7M | 0.01% |
230,084
+1,466
| +0.6% | +$93.8K |
|
195
American Express
AXP
$230B
| $14.2M | 0.01% |
141,786
| – | – |
|
196
Sherwin-Williams
SHW
$91.2B
| $13.3M | 0.01% |
57,237
| – | – |
|
|
UBX
197
DELISTED
Unity Biotechnology
UBX
| $13.2M | 0.01% |
380,301
| – | – |
|
|
ATVI
198
DELISTED
Activision Blizzard Inc.
ATVI
| $13.1M | 0.01% |
161,314
-1,649,985
| -91% | -$134M |
|
199
TJX Companies
TJX
$157B
| $13M | 0.01% |
234,248
+4,239
| +2% | +$236K |
|
200
Axogen
AXGN
$709M
| $12.6M | 0.01% |
1,080,684
-448
| -0% | -$5.21K |
|